We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
Error prompts life assurance customers to pause or review relationship with early detection biotech
World’s biggest gene sequencing company rejects EU’s fast- track application
Vote to remove John Thompson is the culmination of one of the largest shareholder activism campaigns in years
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
Gene sequencing company heads for pivotal vote in battle with activist investor Carl Icahn
Development chief raises worry over innovation after FTC sues to block Amgen-Horizon deal
Leonard Schleifer supportive of FTC’s lawsuit against takeover of Horizon Therapeutics
US regulator sues to block takeover of biotech group Horizon Therapeutics
Strong personal interest in healthcare among reasons for increase in flow of family office money into venture capital
US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic
Move will see the British healthcare start-up return to private ownership
Proxy adviser says the two executives failed to take responsibility for destructive deal for Grail
Ascend is buying up manufacturing facilities from cash-strapped cell and gene therapy companies
French pharma group needs new assets after trial failure of cancer treatment amcenestrant
Japanese companies are seeking growth beyond their shrinking domestic market
Modest size of acquisition leaves the UK pharma group well positioned to make further bolt-on deals
UK pharma group agrees to buy Bellus Health in effort to strengthen pipeline
MGI Tech insists it can succeed even though parts of its former parent BGI Group have been blacklisted
The corporate world is using ‘biomimicry’ to harness the genius of nature and find sustainable solutions
Pharmaceutical and biotech deals are rebounding after a dip last year
Smart Immune is developing technology it hopes will help patients rebuild their immune systems
Washington has designated the sector as a strategic industry and may introduce export curbs
Founding directors say political wrangling causing delays to potentially life-saving blood test
FTC warns acquisition would hurt competition in the market for early detection cancer tests
International Edition
